- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 284 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 273 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 276 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 377 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 179 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 475 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 477 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 185 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 372 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 369 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 383 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 268 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 277 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 279 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 468 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 378 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 369 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 366 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more